Terns Pharmaceuticals Inc Financial Flexibility Index
Terns Pharmaceuticals Inc financial flexibility index. Terns Pharmaceuticals Inc (TERN) has a Financial Flexibility Index of -1.12x as of September 2025. Free cash flow of $-19.77 Million (operating CF $-19.77 Million minus capex $0.00) represents -1% of total liabilities ($17.59 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Terns Pharmaceuticals Inc (2018–2024)
Financial flexibility index of Terns Pharmaceuticals Inc from 2018 to 2024. Historical Financial Flexibility Index trend for Terns Pharmaceuticals Inc across 7 annual periods. Explore how well can Terns Pharmaceuticals Inc service its debt to assess how comfortably operating cash covers total debt obligations.
Terns Pharmaceuticals Inc Financial Flexibility Index by Year (2018–2024)
Terns Pharmaceuticals Inc financial flexibility index by year from 2018 to 2024. Year-by-year free cash flow to debt coverage for Terns Pharmaceuticals Inc. For the full cash flow conversion analysis, see cash flow conversion of Terns Pharmaceuticals Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -3.87x | $-69.97 Million | $-70.02 Million | $18.06 Million | ▲ +24.3% |
| 2023 | -5.12x | $-67.34 Million | $-67.39 Million | $13.15 Million | ▼ -5.7% |
| 2022 | -4.84x | $-48.83 Million | $-49.11 Million | $10.08 Million | ▲ +9.3% |
| 2021 | -5.34x | $-41.49 Million | $-41.83 Million | $7.77 Million | ▼ -333.1% |
| 2020 | -1.23x | $-29.23 Million | $-29.81 Million | $23.70 Million | ▲ +89.5% |
| 2019 | -11.71x | $-65.32 Million | $-66.22 Million | $5.58 Million | ▼ -1006.0% |
| 2018 | -1.06x | $-17.83 Million | $-18.07 Million | $16.84 Million | — |